Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Ravin Ratan, MD, MEd

Advertisement

Articles by Ravin Ratan, MD, MEd

Ravin Ratan, MD, MEd

Dr. Ratan on the Steps of Diagnosing Desmoid Tumors

ByRavin Ratan, MD, MEd
January 3rd 2022

Ravin Ratan, MD, MEd, discusses the steps that should be taken to diagnose desmoid tumors.

Advertisement

Latest Updated Articles

  • Ravin Ratan, MD, MEd
    Dr. Ratan on the Steps of Diagnosing Desmoid Tumors

    January 3rd 2022



Advertisement
Advertisement

Trending on OncLive

1

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

2

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

3

Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS

4

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

5

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us